| Joseph Papa | President, Chief Executive Officer and Director | FY2025 | |
| Richard Lindahl | Executive Vice President, Chief Financial Officer | FY2025 | |
| Coleen Glessner | Executive Vice President, Quality and Ethics and Compliance | FY2025 | |
| Simon Lowry | Chief Medical Officer and Head of Research and Development | FY2025 | |
| Paul Williams | Senior Vice President, Products Business | FY2025 |
5 executives
Named executives and their total pay come from the Summary Compensation Table of the latest proxy statement.